The patent litigation relates to the companies’ continuous glucose monitor (CGM) technologies. Abbott and Dexcom are two ...

The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of ...

There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

[Image courtesy of Dexcom/Oura] Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health monitoring ...

The Vivani NanoPortal technology. [Image courtesy of Vivani] Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.